Medical College of Wisconsin
CTSIResearch InformaticsREDCap

CURRICULUM VITAE

David Johnstone MD
Emeritus Professor
Department of Surgery
Division of Surgery Cardiothoracic

OFFICE ADDRESS:
Remote-Exception
Remote Location
Madison, WI 53702

EDUCATION:
1975 Valedictorian, Shorewood High School, Shorewood, WI
1979 BS - Biology, Yale University, New Haven, CT
1984 MD, Northwestern University Medical School, Chicago, IL

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1984 - 1989 General Surgery Residency, Columbia-Presbyterian Medical Center, New York, NY
1988 - 1989 Administrative Chief Resident, Columbia-Presbyterian Medical Center, New York, NY
1989 - 1990 Instructor in Surgery, Trauma and Critical Care, Columbia-Presbyterian Medical Center, New York, NY
1990 - 1992 Cardiothoracic Surgery Residency, Memorial Sloane-Kettering Cancer Center, Cornell University Medical Center - New York Hospital, New York, NY
1990 - 1992 2 month exchange rotation, Toronto General Hospital, Toronto, ON

FACULTY APPOINTMENTS:
1989 - 1990 Instructor in Surgery, Trauma and Critical Care, Columbia-Presbyterian Medical Center, New York, NY
1993 - 1999 Assistant Professor of Surgery, Division Cardiothoracic Surgery, University of Rochester School of Medicine, Rochester, NY
1998 - 1999 Assistant Professor of Oncology, University of Rochester School of Medicine, Rochester, NY
1999 - 2004 Associate Professor of Oncology, University of Rochester School of Medicine, Rochester, NY
1999 - 2004 Associate Professor of Surgery, University of Rochester School of Medicine, Rochester, NY
2004 - 2011 Associate Professor of Surgery, Dartmouth Medical School, Hanover, NH
2007 - 2011 Chief, Section of Cardiothoracic Surgery, Division of Thoracic Surgery, Dartmouth Hitchcock Medical Center
2010 - 2011 Director, Norris Cotton Cancer Center, Comprehensive Thoracic Oncology Program, Dartmouth Hitchcock Medical Center
2011 Professor of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, WI
2011 Director, Thoracic Oncology Program, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1992 - 1993 Cardiothoracic Surgeon, Cardiothoracic & Vascular Surgical Associates, Oak Lawn, IL
1993 - 2004 Attending Surgeon, University of Rochester School of Medicine, Rochester, NY
2004 - 2011 Attending Surgeon, Dartmouth Hitchcock Medical Center
2011 - Present Attending Surgeon, Froedtert Memorial Lutheran Hospital, Milwaukee, WI
2011 - Present Attending Surgeon, St. Joseph’s Hospital, West Bend, WI

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
American Board of Surgery: Surgical Critical Care
1990
2011
American Board of Surgery
#572
1990
2010
American Board of Thoracic Surgery
06/04/1993
2003
Recertification
2002
2013
    

Licensure
Number Issue DateExpiration
New York License (inactive)
1984
1984
Illinois License (inactive)
1992
1992
New Hampshire License
12427
2004
None
Wisconsin License
55565-20
2011
2011
    

AWARDS AND HONORS:
1983 Honor Society, Alpha Omega Alpha
1999 Good Housekeeping Magazine, Cancer Doctors
2005 Nomination for Excellence in Teaching Award, Dartmouth Medical School
2006 Nomination for Excellence in Teaching Award, Dartmouth Medical School
2007 - 2012 Best Doctors in America listing
2008 - 2010 Top Doctor, New Hampshire Magazine
2011 - 2012 Best Doctor, The Business Journal Greater Milwaukee
2012 Arthur Naitove Department of Surgery Distinguished Teaching Award , Dartmouth Hitchcock Medical Center

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1983 Alpha Omega Alpha Honor Society (Member)
1984 American Medical Association (Member)
1991 American College of Surgeons (Member)
1992 General Thoracic Surgical Club (Member)
1993 Monroe County Medical Society (Member)
1993 New York Upstate Thoracic Society (Member)
1993 Rochester Academy of Medicine (Member)
1993 Radiation Therapy Oncology Group (RTOG) (Member)
1993 Eastern Cooperative Oncology Group (Member)
1994 Society of Thoracic Surgeons (Member)
1994 American College of Chest Physicians (Member)
1996 Protocol 9511 (Talc Pleurodesis) (RTOG Principal Investigator)
1996 International Association Study of Lung Cancer (Member)
1998 - 2003 Protocol 9705 (Adjuvant NSCLC) (RTOG Principal Investigator)
2000 Southwestern Oncology Group (Member)
2000 - 2002 Interventional and Diagnostic Procedures Network (Chair)
2002 - 2004 Interventional and Diagnostic Procedures Network (Ex-officio member)
2004 Cancer and Leukemia Group B (Member)
2004 New Hampshire Medical Society (Member)
2005 - Present Thoracic Oncology Network (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
1994 - Present Chest
1995 - Present Southern Medical Journal
1997 - Present Annals of Thoracic Surgery
1998 - Present Journal of the American College of Surgeons
1998 - Present Journal of Thoracic and Cardiovascular Surgery
2001 Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1993 - 1997 Member, Thoracic Surgery Subcommittee
1993 - 1997 Member, Thoracic Surgery Subcommittee, Radiation Therapy Oncology Group
1996 - 2000 Member, Thoracic Surgery Subcommittee
1996 - 2005 Member, Surgery Quality Assurance Subcommittee
1996 Site RTOG Principal Investigator, Protocol 9511, Radiation Therapy Oncology Group
1996 - 2004 Member, Surgery Quality Assurance Subcommittee, Radiation Therapy Oncology Group
1997 - 2004 Chair, RTOG Thoracic Surgical Subcommittee, Radiation Therapy Oncology Group
1997 - 2005 Co-chair, RTOG Lung Committee
1997 - 2004 Co-chair, RTOG Lung Committee, Radiation Therapy Oncology Group
1997 - 2005 Chair, RTOG Thoracic Surgical Subcommittee, NCI Grant CA21661-29
1998 - 2000 Member, Cancer Center Peer Review Committee, URMC
1998 - 2003 Principal Investigator, Protocol 9705 (Adjuvant NSCLC), Radiation Therapy Oncology Group
1999 - 2002 Member, Scientific Program Committee
2001 - 2003 Principal Investigator, Protocol 9909 (Adjuvant NSCLC), Radiation Therapy Oncology Group
2002 - 2006 Member, Continuing Education Committee
2003 - 2005 Member, Nominating Committee
2003 - 2004 Member, National Lung Screening Trial Data Safety Monitoring Board, National Institutes of Health

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1993 - 2001 Member, Thoracic Surgery Subcommittee, Eastern Cooperative Oncology Group
2000 Member, Thoracic Committee, American College of Surgeons Oncology Group
2000 Member, Thoracic Surgery Committee, American College of Surgeons Oncology Group
2000 - 2004 Site Chair, UR Medical Center ACOSOG, American College of Surgeons Oncology Group
2000 - 2004 Member, Southwestern Oncology Group
2002 Board Examiner, American Board of Thoracic Surgery
2003 In-Training Examination Consultant, General Thoracic Subcommittee
2004 In-Training Examination Consultant, General Thoracic Subcommittee
2004 - Present Member, Cancer and Leukemia Group B
2005 - Present Institutional Surgery Representative for DHMC, Cancer and Leukemia Group B
2005 - 2011 Member, Proof-of-principle trials of targeted therapy for resectable lung cancer, Dartmouth Hitchcock Medical Center
2006 - 2011 Member, Prospective randomized trial of two methods of rib closure, Dartmouth Hitchcock Medical Center
06/2008 CALGB Audit Team Member, Cancer and Leukemia Group B
2008 - 2011 Member, Randomized trial of adjuvant erlotinib following lung cancer resection, Dartmouth Hitchcock Medical Center
Member, ACOSOG Z0040, American College of Surgeons Oncology Group
Member, ACOSOG Z4032, Dartmouth Hitchcock Medical Center

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Prior
Peer Review
Title:
Retrospective study of URMC laser bronchoscopy experience
Source:
University of Rochester
Role & Effort:
Principal investigator
PI:
Self
Dates:
1979 - 1980
  
Title:
Prospective trial of intraoperative pleural lavage in patients undergoing resection of non-small cell lung cancer
Source:
URCC U1598
Role & Effort:
Principal investigator
PI:
Self
Dates:
1979 - 1980
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Preoperative Assessment of the Thoracic Surgical Patient, Discussion. Cardiothoracic Surgery Fellows Program, American College of Chest Physicians 71st Int. Scientific Assembly, Montreal, Quebec, 10/30/2005
Benign and Malignant Disorders of the Esophagus, Cardiothoracic Surgery Fellows Program, American College of Chest Physicians 71st Int. Scientific Assembly, Montreal, Quebec, 10/30/2005
Preoperative Assessment of the Thoracic Surgical Patient, Discussion, Cardiothoracic Surgery Fellows Program, American College of Chest Physicians 71st Int. Scientific Assembly, Montreal , Quebec, 10/30/2005
Preoperative Assessment of the Thoracic Surgical Patient, American College of Chest Physicians 71st Int. Scientific Assembly, Montreal, Quebec, 11/01/2005
 
National
Laser Bullectomy, General Thoracic Surgical Club, 8th Annual Meeting, Captiva Island, FL, 03/1995
Lung Volume Reduction for Emphysema: Hope or Hype?, New York State Thoracic Society, 1996 Annual Scientific Assembly, West Point, NY, 01/1996
Surgical Treatment of Emphysema. Upstate New York Chapter of the American College of Surgeons, 18th Annual Symposium, Geneva, NY, 05/1996
Complications of Thoracoscopic Lung Volume Reduction, Faculty, Minimally Invasive Thoracic Surgery Interest Group, Harvard University, 09/1996
Surgery for Lung Cancer, At Workshop on Lung Cancer: Improving Outcomes for the New Millenium. Alliance for Lung Cancer Advisory Support and Education, Bethesda, MD, 09/11/1997 - 09/14/1997
Current Management of Empyema, ACCP 63rd Int. Scientific Assembly, New Orleans, LA, 10/26/1997
Endoluminal Treatment of Tracheobronchial Obstruction, American College of Chest Physicians 63rd Int. Scientific Assembly, New Orleans, LA, 10/27/1997
Neoadjuvant / Adjuvant Therapy for Non-small Cell Lung Cancer, American College of Surgeons Thoracic Surgery Postgraduate Course, San Francisco, CA, 10/11/1999
Thoracic Surgery Postgraduate Course, Am Coll Chest Physicians 66th Int. Scientific Assembly, San Francisco, CA, 10/22/2000
Mediastinal Lymph Node Dissection Improves Survival in Patients with Non-small Cell Lung Cancer: Pro-Con Debate, Am Coll Chest Physicians 66th Int. Scientific Assembly, San Francisco, CA, 10/25/2000
Postoperative Complications in Pulmonary Surgery, 32. Postoperative Am Coll Chest Physicians 67th Int. Scientific Assemblyin Pulmonary Surgery, Phildelphia, PA, 11/17/2001
Presentation of ACCP Interventional and Diagnostic Procedures Practice Guidelines (pre-publication in CHEST), Am Coll Chest Physicians 68th Int. Scientific Assembly, San Diego, CA, 11/06/2002
Multimodality Therapy for Lung Cancer Monmouth Surgical Society, Long Branch, NJ, 09/2003
Lung Volume Reduction and Transplantation for COPD, American Lung Association, Rochester, NY, 02/2004
Multimodality Therapy for Lung Cancer: Update 2004, Springfield Hospital, Springfield, VT, 09/2004
Multimodality Therapy for Lung Cancer: Update 2004, American College of Chest Physicians 70th Int. Scientific Assembly, Seattle, WA, 10/24/2004
Surgical Management of Esophageal Carcinoma, American College of Chest Physicians 70th Int. Scientific Assembly, Seattle, WA, 10/24/2004
Decision Making in Benign & Malignant Esophageal Lesions, ACCP Cardiothoracic Surgery Fellows Course, Salt Lake City, UT, 10/22/2006
Adjuvant Therapy for Lung Cancer: Results and Implications, Society of Thoracic Surgeons Tech-Con Symposium, San Diego Convention Center, San Diego, CA, 01/27/2007
Molecular Profiling in Early Stage Lung Cancer, DHMC Comprehensive Thoracic Oncology Program Retreat, Minary Center, Squam Lake, NH, 04/26/2007
The Role of PET CT in Lung Cancer: A Surgeon’s Perspective, Frontline of PET CT Symposium, Mount Washington Bretton Woods, NH, 03/15/2008
Management of Lung Cancer: A Surgical Perspective, Quarterly Meeting, DHMC Nashua, 09/2008
Decision Making in Benign & Malignant Esophageal Lesions, ACCP Cardiothoracic Surgery Fellows Course, Phildelphia, PA, 10/26/2008
Management of Lung Cancer: A Surgical Perspective, Catholic Medical Center, Manchester, NH, 10/2008
The Role of PET CT in Lung Cancer: A Surgeon’s Perspective, Frontline of PET CT Symposium, Mount Washington Bretton Woods, NH, 03/2009
Multimodality Treatment of Lung Cancer: Incremental Progress and Future Directions, Department Cardiothoracic Surgery, University of Texas Southwestern, 09/2010
Surgery for Lung Cancer – Staging, Strategy, Technique, and Pathologic Considerations, Pathology Grand Rounds, Dartmouth Hitchcock Medical Center, Lebanon NH, 02/2011
The Role of PET CT in Lung Cancer, Frontline of PET CT Symposium, Dartmouth Hitchcock Medical Center, Stowe, VT, 03/2011
 
Regional
Neoadjuvant Therapy for Stage III Non-Small Cell Lung Cancer, American College of Chest Physicians Cardiothoracic Surgery Postgraduate Course, Chicago, IL, 10/31/1999
Neoadjuvant Therapy for Lung Cancer, ACCP-STS Multidisciplinary Care of Thoracic Surgery Patients Course, Chicago, IL, 08/25/2006
Thoracoscopy in Lung Cancer Staging, ACCP-STS Multidisciplinary Care of Thoracic Surgery Patients Course, Chicago, IL, 08/25/2006
Mediastinoscopy, ACCP-STS Multidisciplinary Care of Thoracic Surgery Patients Course, Chicago, IL, 08/26/2006
Decision Making in Benign & Malignant Esophageal Lesions, ACCP Cardiothoracic Surgery Fellows Course, Chicago, IL, 10/21/2007
 
Local
Surgical Management of Lung Cancer, Heme/Onc Fellows Core Lecture Series, DHMC, 09/2009
The Role of PET CT in Lung Cancer, Frontline of PET CT Symposium, Mount Washington Bretton Woods, NH, 03/2010
Multimodality Treatment of Lung Cancer: Incremental Progress and Future Directions, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, 05/10/2010
Treatment of Early Stage Lung Cancer: Challenges to the Surgical Paradigm, Cardiothoracic Surgical Conference, Medical College of Wisconsin, Milwaukee WI, 10/2011
Multimodality Treatment of Lung Cancer: Incremental Progress and Future Directions, CME Conference, St. Joseph’s West Bend, West Bend WI, 11/2011
 

EXTRAMURAL TEACHING:
Medical Student Education
08/25/2006 - 08/26/2006 ACCP-STS Multidisciplinary Care of Thoracic Surgery Patients Course, Chicago IL, Course Director
10/2008 ACCP Cardiothoracic Fellows Symposium, Chicago IL, Course Co-Director
10/2011 Medical College of Wisconsin 1st year Biochemistry: Lipid Metabolism, clinical correlation, Course Preceptor
12/2011 Medical College of Wisconsin 2nd year Neoplasia module: Neoplasia & Inflammation; Chemoprevention, Course Preceptor
 

RESEARCH ACTIVITIES:
1979 - 1980 Research (Prokaryotic Molecular Genetics) Terry Platt, PhD Department of Molecular Biology and Biophysics Yale University

RESEARCH INTERESTS:
Multimodality treatment of lung cancer
Clinical trials in treatment of lung cancer
Outcomes in surgery for esophageal cancer

TEACHING EXPERIENCE/CURRENT TEACHING RESPONSIBILITIES:
Residents & Postdoctoral Fellows Weekly thoracic surgical conferences Teaching rounds daily Weekly multimodality thoracic oncology conference Clinic teaching weekly Operative supervision


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, et al. Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models. Cancer Prev Res 2011;4:818-28.
2. Chen Y, Pandya KJ, Hyrien O, Keng PC, Smudzin T, Anderson J, Qazi R, Smith B, Watson TJ, Feins RH, Johnstone DW. Preclinical and Pilot Clinical Studies of Docetaxel Chemoradiation for Stage III Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2011; 80:1358-64.
3. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A. Bezjak A, Videtic G, Johnstone D, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070-1076.
4. Strauss GM, Herndon JE, Maddeus MA, Johnstone DW, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small cell lung cancer: CALGB 9633 with the CALGB, RTOG, and NCCTG study groups. J Clin Oncol 2008; 26:5043-51.
5. Chen Y, Pandya KJ, Feins R, Johnstone D, et al. Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 71:407-13.
6. Chang JY, Moughan J, Johnstone D, et al. Surgical patterns of care in operable lung carcinoma treated with radiation. J Thorac Oncol 2006; 1:526-531.
7. Johnstone DW. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion. (Editorial) J Surg Oncol 2006; 93:255-256.
8. Dacey LJ, Johnstone DW. Reducing the risk of lung cancer. (Editorial) JAMA 2005; 294:1550.
9. Hendrickson RJ. Killackey MT. Watson TJ. Johnstone DW. Feins RH. Image of the month. Small left apical pneumothorax, left tube thoracostomy, and a prominent right central pulmonary artery. Arch Surg 2004; 139:1017-18.
10. Bradley JD, Johnstone DW, et al. A phase II trial of postoperative adjunctive paclitaxel / carboplatin and thoracic radiotherapy in resected stage II and IIIA nonsmall cell lung cancer (NSCLC) - promising long term results for RTOG 9705. J Clin Oncol 2005; 23:3480-7.
11. Hendrickson RJ. Killackey MT. Watson TJ. Johnstone DW. Feins RH. Image of the month. Small left apical pneumothorax, left tube thoracostomy, and a prominent right central pulmonary artery. Arch Surgery 2004;139(9):1017-18.
12. Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, et al. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 2003; 21:4553-59.
13. Johnstone DW. Invited editorial: Role of adjuvant therapy in resected stage II/IIIA non-small cell lung cancer - the Movsas article reviewed. Oncology 2002, 16:102-103.
14. Fultz PJ, Harrow AR, Elvey SP, Feins RH, Strang JG, Wandtke JC, Johnstone DW, et al. Sonographically guided biopsy of supraclavicular lymph nodes: a simple alternative to lung biopsy and other more invasive procedures. AJR 2003;180:1403-1409.
15. Ernst A, Silvestri GA, Johnstone D, et al. Interventional Pulmonary Procedures: Guildelines from the American College of Chest Physicians. Chest 2003;123:1693-1717.
16. Chen Y, Pandya K, Keng PC, Johnstone D, et al. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin Cancer Res 2003;969-975.
17. Johnstone DW, Byhardt RW, Ettinger D, Scott CB. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Int J Rad Oncol Biol Phys 2002;54:309-628.
18. Fultz PF, Feins RH, Strang JG, Wandtke JC, Johnstone DW, Watson TJ, Gottlieb RH, Voci SL, Rubens DJ. Detection and diagnosis of nonpalpable supraclavicular lymph nodes in lung cancer at CT and US. Radiology 2002;222(1):245-51.
19. Ginsburg R, Bullard D, Eisenberg B, Gomella L, Johnstone D, et al. Radiation Therapy Oncology Group. Research Plan 2002-6. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys 2001; 51: 44-52, 92-95.
20. Wain JC, Kaiser LR, Johnstone DW, Yang SC, Wright C, Friiedberg J, Feins RH, Heitmiller RF, Mathisen DJ, Selwyn M. A randomized controlled trial of a novel synthetic surgical sealant in preventing air leaks after lung resection. Ann Thorac Surg 2001; 71:1623-8.
21. Feins RH, Johnstone DW, Barones ES, O'Neil SM. Palliation of inoperable esophageal carcinoma with the Wallstent endoprosthesis. Ann Thorac Surg 1996;62:1603-7.
22. Serletti JM, Feins RH, Carras AJ, Losee JE, Johnstone DW, Herrera HR, Hicks GL. Obliteration of empyema tract with deepithelialized unipedicle transverse rectus abdominis myocutaneous flap. J Thorac Cardiovasc Surg 1996;112:631-6.
23. Hazelrigg S, Boley T, Henkle J, Lawyer C, Johnstone D, Naunheim K, Keller C, Keenan R, Landreneau R, Sciurba F, Feins R, Levy P, Magee M. Thoracoscopic laser bullectomy: a prospective study with three-month results. J Thorac Cardiovasc Surg 1996;112:319-27.
24. Smith PH, Schwartz RH, Rosenfeld SI, Johnstone DW. Bilateral, recurrent spontaneous pneumothorax in a male adolescent with chronic asthma: a case for protease-antiprotease imbalance. Ped Asthma Allergy & Immunology 1996: 10:191-195.
25. Johnstone DW, Forde KA, et al. Gastric duplication cyst communicating with the pancreatic duct: a rare cause of recurrent abdominal pain. Surgery 1991;109:97-100.
 
Books, Chapters, and Reviews
1. Hoenig MR, Johnstone DW. Postpneumonectomy Syndrome. In Cardiothoracic Surgery Review (1st Ed.), eds. Franco KL & Thourani VH. Lippincott Williams & Wilkins, 2011.
2. Goldberg JB, Johnstone DW. Mediastinoscopy. In Cardiothoracic Surgery Review (1st Ed.), eds. Franco KL & Thourani VH. Lippincott Williams & Wilkins, 2011.
3. Johnstone DW. Anatomy of the thoracic duct and Chylothorax. In General Thoracic Surgery (7th Ed.), ed. Shields TW et al. Lippincott Williams & Wilkins 2009.
4. Cortina RM, Johnstone DW. Chylothorax. In Current Therapy in Thoracic and Cardiovascular Surgery. Ed. Yang, S and Cameron, DE. Mosby Yearbook 2004.
5. Johnstone DW. Postoperative Chylothorax. Chest Surg Clin N Amer 2002;12:597-603.
6. Johnstone DW, Dresler CM. Malignant Pleural Effusions. In Minimal Access Cardiothoracic Surgery. Ed. Yim, Hazelrigg, Izzat, Landreneau, Mack & Naunheim. WB Saunders, 2000.
7. Johnstone DW. Hemothorax: Diagnosis and Management. In Pulmonary and Critical Care Update, 1998; Vol 13, Lesson 4. American College of Chest Physicians. Ed. S. Sahn.
8. Johnstone DW, Afifi H. The Role of Chemotherapy and Surgery in the Treatment of Locally Advanced Non-small Cell Lung Cancer. In Updates in Advances in Lung Cancer. Ed. JH Schiller. S Karger AG, Basel, Switzerland (1997); 29:21-34.
9. Johnstone DW, Feins RH. Chylothorax. Chest Surgery Clinics of North America 1994; 4:617-28.
10. Johnstone DW, Ginsberg RJ. Pleural and pulmonary sepsis. Chest Surgery Clinics of North America 1992; 1:369-84.
 
Abstracts
1. Strauss GM,Wang XF, Maddaus M, Johnstone D, et al. Adjuvant chemotherapy (AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633. J Clin Oncol 29: 2011 (suppl; abstr 7015)
2. Dragnev KH, Ma T, Galimberti F, Erkmen CP, Memoli V, Nugent W, Rigas JR, Johnstone D, et al. A window of opportunity trial of vorinostat (V) in patients with resectable non-small cell lung cancer (NSCLC). J Clin Oncol 29: 2011 (suppl; abstr 7062)
3. Rigas JR, Abraham KL, Dragnev KH, Delong PA, Johnstone D, et al. Accrual to adjuvant targeted clinical trials in resected non-small cell lung cancer: more hold in the "leaky pipe." International Assoc Study of Lung Cancer, Amsterdam, July 2011.
4. Paravati A, Johnstone D, Johnstone C. Negative predictive value of PET-CT in node-negative early stage lung cancer: implications for non-surgical management. International Assoc Study of Lung Cancer, Amsterdam, July 2011.
5. Ma T, Galimberti R, Erkmen DP, Memoli V, Nugent W, Rigas J, Johnstone D, et al. Murine transgenic lung cancer models guide a window of opportunity vorinostat trial in lung cancer patients. International Assoc Study of Lung Cancer, Amsterdam, July 2011.
6. Paravati AJ, Johnstone DW, Aitken CL, et al. Single-institution experience with stage IB non-small cell carcinoma in adjuvant chemotherapy era. 13th World Conference on Lung Cancer, IASLC. San Francisco CA, August 2, 2009.
7. Aitken D, Johnstone D, Recht A, Seltzer M. Excellent Negative Predictive Value (NPV) of early PET-CT in the follow-up of pts treated with Stereotactic Radiation Therapy (SRT). (Poster presentation.) Multidisciplinary Symposium in Thoracic Oncology. Nov 13-15, 2008.
8. Freemantle S, Feng Q, Liu X, Black C, Memoli V, Nugent W, Johnstone DW, et al. Uncovering retinoid chemoprevention mechanisms. British Association for Cancer Research Special Conference on "Diet and cancer; susceptibility, prevention and therapy." June 18-19,2007, University of Nottingham, UK.
9. Dragnev KH, Feng Q, Ma Y, Shah SJ, Black C, Memoli V, Nugent W, Johnstone DW, Rigas JR, Kitareewan S, Freemantle S, Dmitrovsky E. Cyclin D1 as a molecular target in cancer therapy and prevention. MCETC 4th Annual Meeting, Montreal, October 26, 2006.
10. Y. Chen, K. J. Pandya, T. Smudzin, R. Qazi, B. D. Smith, O. Hyrien, DW Johnstone, et al. Phase II study of induction docetaxel/cisplatin with rhG-CSF followed by concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC). J Clin Oncol 2006; ASCO Proceedings 24 (18S): 17034
11. Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2006; ASCO Proceedings 24 (18S): 7007.
12. Chen Y; Pandya K; Smudzin, T; Anderson J; Qazi R; Smith B; Hyrien O; Johnstone DW; Watson TJ; Feins RH. A phase II study of induction docetaxel/cisplatin with RHG-CSF and concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer. ASTRO October 2005, Denver CO.
13. Pisters K, Vallieres E, Bunn P, Crowley J, Ginsberg R, Ellis P, Johnstone D, et al. S9900: Phase III trial of surgery alone or surgery plus preoperative paclitaxel/carboplatin chemotherapy in early stage NSCLC: preliminary results. PASCO May 13-17, 2005. Orlando FL. Abstract LBA7012
14. Johnstone DW, Moughan J, Goldberg M, Langer C, Owen J, Movsas B. Radiotherapy patterns of care study in lung cancer: analysis of surgical cohort. ASTRO Meeting Abstract 2004: 2318.
15. Strauss GM, Herndon J, Maddaus MA, Johnstone DW, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer: report of CALGB protocol 9633. ASCO Meeting Abstracts 2004 22: 7019.
16. Chen Y, Pandya K, Smudzin T, Johnstone DW, et al. A phase II induction docetaxel.cisplatin with rhG-CSF and concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer. ASCO Meeting Abstracts 2004 22: 7273.
17. Chen Y, Pandya K, Peter Keng, Richard Raubertas, Marie Flannery, Joseph Rosenblatt, David Johnstone, et al. Comparable Toxicity and Quality of Life for Elderly Patients Receiving Concurrent Pulsed Low-Dose Paclitaxel Chemoradiation for Non-Small-Cell Lung Cancer. ASCO Meeting Abstracts 2001: 2858.
18. Graham M, Ettinger DS, Johnstone D, et al. Preliminary results of a radiation therapy oncology group (RTOG) trial 97-05, a phase II study of postoperative adjuvant therapy in patients with completely resected stage II and stage IIIA non-small cell lung cancer. 9th World Conference on Lung Cancer, 2000.
19. Fultz PJ, Feins RH, Strang JG, Wandtke JC, Johnstone DW, Watson TJ, et al. CT and ultrasound for detection and diagnosis of non-palpable supraclavicular adenopathy in lung cancer. Radiology 2000; 214:611.
20. Hughes DJ, Johnstone D. Lung volume reduction surgery: an objective and subjective evaluation. Respir Care 1997;42(11):1086.
21. Chen Y, Yu Y, Makamura C, McDonald S, Philip A, Smudzin T, Johnstone D, Feins R, Rubin P. Risk estimate of fatal hempotysis following high dose rate endobronchial brachytherapy using dose-volume and dose-length analysis. Radiotherapy and Oncology 1997;43:S73.
22. Johnstone DW, Feins RH, Barones E, O'Neill S. Treatment of tracheobronchial obstruction with the Wallstent prosthesis. Am Rev Resp Disease 1997;155:A479.
23. Chen Y, Yu Y, McDonald S, Nakamura C, Philips A, Ojomo K, Hernady E, Williams JP, Smudzin T, Johnstone D, Feins R, Speiser BL, Rubin P. Bronchial mucosal tolerance following high dose rate endobronchial brachytherapy: clinical and laboraory correlates in late complication assessment of fatal hemoptysis. IJ Radiation Oncol 1996; 36:352.
24. Munir M, Johnstone DW, Jin HO, Hyde RW, Potter GD. Prevalence of motility disorders in patients with chronic obstructive pulmonary disease (COPD). Presented at the American Gastroenterological Association Meeting, San Francisco, May 1995.
25. Rubin P, McDonald S, Ojomo K, Feins RH, Johnstone DW. The "target volume" in lung cancer. IASLC Workshop, August 1993.